TrialResults-center.org
Search
Menu
Home
Search
Recent trials
Browse pathology
Browse treatment
About us
Avelumab
immune checkpoint inhibition
Description
Results
NMA
MSB0010718C - avelumab
Group by
Group by...
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
clinical condition
in first
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
clinical condition
in second
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
clinical condition
in third
lung cancer (metastatic)
renal-cell carcinoma (advanced)
urothelial carcinoma (advanced)
death (overall survival)
progression or death (progression free survival PFS)
objective response (ORR)
Grade 3–5 drug-related AEs
complete response (CR)
pdf
pathology
Demonstrated benefit and harm
k
×
Modal title